Evaluation of Anti-venoms Serum in Africa

CompletedOBSERVATIONAL
Enrollment

474

Participants

Timeline

Start Date

October 17, 2019

Primary Completion Date

September 14, 2021

Study Completion Date

September 14, 2021

Conditions
Snake BitesAntiveninsSnake Venoms
Interventions
DRUG

Antivenom serum Inoserp Pan-Africa® injection

Participation to the study does not change usual follow-up of patients. All medical procedures will be performed and products will be used in a routine manner. Antivenom serum Inoserp Pan-Africa® injection will be decided according to the clinical evaluation of the patient.

Trial Locations (13)

Unknown

Hôpital de District d'Akonolinga, Akonolinga

Hôpital régional de Buea, Buea

Hôpital de District de Guider, Guider

Hôpital de District de Kolofata, Kolofata

Hôpital Régional de Limbe, Limbe

Hôpital de District de Mora, Mora

Hôpital Norvégien de N'Gaoundéré, N'Gaoundéré

Hôpital Régional de N'Gaoundéré, N'Gaoundéré

Hôpital Saint Malte de Njombe, Njombé

Hôpital de District de Poli, Poli

Hôpital de District de Sa'a, Sa'a

Hôpital de District de Tokombere, Tokonbéré

Centre des Urgences de Yaounde (CURY), Yaoundé

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

Cameroon Society of Epidemiology (CaSE)

UNKNOWN

collaborator

Centre International de Recherches d'Enseignements et de Soins (CIRES)

UNKNOWN

collaborator

Centre Pasteur du Cameroun

OTHER

collaborator

Inosan Biopharma

INDUSTRY

lead

Institut Pasteur

INDUSTRY

NCT03326492 - Evaluation of Anti-venoms Serum in Africa | Biotech Hunter | Biotech Hunter